Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.

Angelika Wagner,Anna Ohradanova-Repic,Laura Gebetsberger,Gabor Tajti,Michael Kundi,Hannes Stockinger,Ursula Wiedermann,Katharina Grabmeier-Pfistershammer

Immunology Letters（2022）

引用 1|浏览9

暂无评分

摘要

•5% non-responder and 3.4% low-responder rate after the first dose of ChAdOx1.•All seroconverted after the second dose and no non-responders.•Higher antibody levels after a heterologous second dose with mRNA-1273.

查看译文

关键词

COVID-19,Vaccination strategy,Humoral immune response,Initial non/low responder,Heterologous COVID-19 vaccine schedule,Antibody testing

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要